Site Selection Strategies in 2025: Leveraging Data-Driven Metrics for Success

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Pharma,
  • Wednesday, July 30, 2025 | 12pm EDT / 11am CDT / 9am PDT / 5pm BST / 6pm CEST
  • 60 min

Despite rapid advances in trial complexity and technology, site selection strategies haven’t kept pace. Most CROs and sponsors still rely on outdated feasibility surveys, static spreadsheets and known investigator relationships, often missing out on sites that are ready and able to deliver today.

This webinar examines how real-world site performance is evolving and why it’s time to modernize how we assess site performance capabilities. The speakers will break down the limitations of traditional feasibility data, explore the metrics that matter most now and show how forward-thinking sites are proactively shaping their own visibility in a competitive market.

Join the featured speakers to explore:

  • The limitations of traditional site selection methods and how they miss opportunities for better-performing sites
  • Insights into the dynamic nature of site visibility and why sites must take a proactive approach to stand out in a competitive market
  • How the right data can transform site selection from a reactive process to a strategic, informed decision-making tool
  • The practical steps CROs and sponsors can take to modernize site assessment and reduce costly delays in trial start-up

Register now to uncover how evolving site selection strategies and data-driven metrics can enhance trial efficiency and outcomes in 2025.

Speakers

Barry Lake, RealTime eClinical Solutions

Barry Lake, Co-Founder & President, Devana, RealTime eClinical Solutions

Barry Lake became frustrated with the inefficiencies of managing trial pipelines and study startup workflows while running a research site. Barry recognized the limitations of traditional CTMS and the inability to effectively capture and analyze site performance metrics.

In response, Barry co-founded Devana, a RealTime eClinical Solutions company, in 2023. Devana’s “category-defining” BI SaaS platform has become essential for leading site networks, automating workflows, capturing performance metrics and differentiating site performance.

Read more...

During the COVID-19 pandemic, while many talked about decentralized clinical trials (DCT), Devana took action by building a cloud platform to host and scale DCTs. The platform allows centralized clinical operations teams at site networks, CROs and sponsors to collaborate with decentralized site-based clinicians globally.

Devana’s latest innovation, TrialAlign, set to be released in 2025, will leverage unbiased trial performance data to transform feasibility and site selection. By connecting and operationally aligning trial sites, sponsors and CROs, it will reduce cycle time and enhance clinical trial execution, speeding up therapeutic advances for patients.

Read Less...

Message Presenter
Michael Bonavilla, RealTime eClinical Solutions

Michael Bonavilla, Executive Director Strategic Partnerships, RealTime eClinical Solutions

With 18 years of experience in clinical research technology, Michael Bonavilla has dedicated his career to creating solutions that streamline clinical trials and accelerate therapies to patients.

Since joining Devana Solutions, now part of RealTime eClinical Solutions, Michael has focused on implementing Devana’s powerful technology in multi-site research centers, health systems and academic medical centers. His work has centred on providing end-to-end functionality, from pipeline management and study start-up workflows to capturing and analyzing critical performance metrics.

Read more...

Michael’s passion lies in understanding each client’s unique needs to ensure the best possible outcomes and maximize their potential through tailored solutions.

Read Less...

Message Presenter
E.B. McLindon, Helios Clinical Research

E.B. McLindon, CEO, Helios Clinical Research

E.B. McLindon is an entrepreneur with extensive experience in executive management, clinical development and business strategy.

Prior to founding Helios Clinical Research, E.B. served as Senior Vice President at ICON plc, where he developed the global clinical research site network, home health provider services, patient recruitment and retention strategies and decentralized clinical trial (DCT) solutions. He has authored numerous white papers on patient engagement and site support, as well as DCT technology deployment.

Read more...

Before his time at ICON, E.B. co-founded Accelovance, a clinical research site network recognized as the Best Vaccine Clinical Research Organization at the World Vaccine Congress in 2009, 2010 and 2011.

Read Less...

Message Presenter

Paul Evans, PhD, President & Chief Executive Officer, Velocity Clinical Research

Paul joined Velocity Clinical Research as President and CEO in 2018 after 26 years of “perfect symmetry” in the site business — he ran sites for 13 years and spent another 13 years managing them on the Sponsor/CRO side. He has served as Corporate VP, Global Site Solutions at Parexel; VP, Global Site Management at IQVIA; and was a Founder and Managing Director of Synexus.

Paul joined Velocity to address one of the fundamental industry challenges. “Patient recruitment is still the biggest problem in clinical trials,” he says. “I want Velocity to set a new industry standard for delivering high-quality study data as quickly and efficiently as possible.” Paul has overseen Velocity’s expansion across the U.S. and into Germany, Poland, the U.K., and, most recently, Latin America.

Read more...

Paul holds a PhD in Biomedical Engineering from the University of London. He has served on the Association of Clinical Research Professionals (ACRP) Board of Trustees since 2017 and chaired the committee in 2020.

Read Less...

Message Presenter

Who Should Attend?

This webinar will appeal to professionals in these roles and departments:

  • Study Start-Up, Feasibility, Site Selection, Site Enablement, Site Engagement, Site Relationships, Site and Patient Centric Solutions
  • Executives and professionals in feasibility and site selection
  • Site and patient-centric solutions leaders from pharma sponsors, CROs and research site organizations
  • Business development professionals focused on growing trial volume and building sponsor relationships for research sites
  • Stakeholders responsible for site enablement, site engagement and strengthening site relationships

What You Will Learn

 Attendees will learn:

  • Why outdated site selection methods persist and the costs they impose on both sites and sponsors
  • Key performance metrics that CROs should prioritize
  • Real-world examples of how data-driven visibility leads to more awarded studies
  • The real metrics helping shorten trial start-up

Xtalks Partner

RealTime eClinical Solutions

RealTime eClinical Solutions is a leading eClinical technology provider reshaping the landscape of clinical trials with its comprehensive eClinical platform. Purpose-built for clinical research sites, site networks, AMCs, sponsors, and CROs, the platform goes beyond traditional CTMS to empower research and business workflows for modern-day clinical trials from trial award and study start-up through to trial execution. RealTime helps organizations manage the research and business of clinical trials, together, with software solutions including CTMS, eReg/eISF, eSource, participant payments (SitePay/GlobalPay), engagement solutions (Text, eConsent, and MyStudyManager™ Participant Portal), and Devana for pipeline management, business intelligence, and process and performance metrics.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account